Last reviewed · How we verify

Qishen Yiqi Drop Pills

China National Center for Cardiovascular Diseases · FDA-approved active Small molecule Quality 2/100

Qishen Yiqi Drop Pills is a Small molecule drug developed by China National Center for Cardiovascular Diseases. It is currently FDA-approved.

At a glance

Generic nameQishen Yiqi Drop Pills
SponsorChina National Center for Cardiovascular Diseases
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Qishen Yiqi Drop Pills

What is Qishen Yiqi Drop Pills?

Qishen Yiqi Drop Pills is a Small molecule drug developed by China National Center for Cardiovascular Diseases.

Who makes Qishen Yiqi Drop Pills?

Qishen Yiqi Drop Pills is developed and marketed by China National Center for Cardiovascular Diseases (see full China National Center for Cardiovascular Diseases pipeline at /company/china-national-center-for-cardiovascular-diseases).

What development phase is Qishen Yiqi Drop Pills in?

Qishen Yiqi Drop Pills is FDA-approved (marketed).

Related